Literature DB >> 29644507

The Impact of Obesity on Breast Cancer.

Daniel F Argolo1, Clifford A Hudis2,3, Neil M Iyengar4,5.   

Abstract

The rates of obesity are increasing worldwide and this condition is now recognized as a leading preventable cause of cancer. Several diseases are directly related to obesity, including diabetes, hypertension, atherosclerosis, stroke, musculoskeletal disorders, and a diverse range of malignances-such as breast cancer. Obesity is associated with an increased risk of postmenopausal estrogen receptor-positive breast cancer and worse cancer-related outcomes for all breast tumor subtypes. Several mechanisms have been proposed to contribute to the obesity-cancer link, including high levels of circulating and local estrogens, altered amounts of adipokines (leptin and adiponectin), disrupted insulin/IGF signaling, modifications within the microbiome, and local and systemic effects of inflammation. Here we will review recent advances in our understanding of the complex signaling pathways underlying the obesity-cancer link. An improved understanding of these processes is anticipated to propel novel and effective intervention strategies to reduce the global obesity-cancer burden.

Entities:  

Keywords:  Adipose tissue; Breast cancer; Inflammation; Insulin; Metabolic syndrome; Obesity

Mesh:

Substances:

Year:  2018        PMID: 29644507     DOI: 10.1007/s11912-018-0688-8

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  89 in total

Review 1.  Endocrinology of adipose tissue - an update.

Authors:  P Fischer-Posovszky; M Wabitsch; Z Hochberg
Journal:  Horm Metab Res       Date:  2007-05       Impact factor: 2.936

Review 2.  The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.

Authors:  Maryann Kwa; Claudia S Plottel; Martin J Blaser; Sylvia Adams
Journal:  J Natl Cancer Inst       Date:  2016-04-22       Impact factor: 13.506

3.  Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer.

Authors:  Neil M Iyengar; Xi Kathy Zhou; Ayca Gucalp; Patrick G Morris; Louise R Howe; Dilip D Giri; Monica Morrow; Hanhan Wang; Michael Pollak; Lee W Jones; Clifford A Hudis; Andrew J Dannenberg
Journal:  Clin Cancer Res       Date:  2015-12-28       Impact factor: 12.531

4.  Stromal estrogen receptor-α promotes tumor growth by normalizing an increased angiogenesis.

Authors:  Christel Péqueux; Isabelle Raymond-Letron; Silvia Blacher; Frédéric Boudou; Marine Adlanmerini; Marie-José Fouque; Philippe Rochaix; Agnès Noël; Jean-Michel Foidart; Andrée Krust; Pierre Chambon; Laurent Brouchet; Jean-François Arnal; Françoise Lenfant
Journal:  Cancer Res       Date:  2012-04-20       Impact factor: 12.701

5.  Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

Authors:  Pamela J Goodwin; Marguerite Ennis; Kathleen I Pritchard; Maureen E Trudeau; Jarley Koo; Yolanda Madarnas; Warren Hartwick; Barry Hoffman; Nicky Hood
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

6.  Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene.

Authors:  Y Zhao; V R Agarwal; C R Mendelson; E R Simpson
Journal:  Endocrinology       Date:  1996-12       Impact factor: 4.736

7.  Venous thromboembolism risk in mastectomy and immediate breast reconstruction: analysis of the 2005 to 2011 American College of Surgeons National Surgical Quality Improvement Program data sets.

Authors:  John P Fischer; Ari M Wes; Charles T Tuggle; Liza C Wu
Journal:  Plast Reconstr Surg       Date:  2014-03       Impact factor: 4.730

8.  The epidemiology of serum sex hormones in postmenopausal women.

Authors:  J A Cauley; J P Gutai; L H Kuller; D LeDonne; J G Powell
Journal:  Am J Epidemiol       Date:  1989-06       Impact factor: 4.897

9.  Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial.

Authors:  Ivana Sestak; Wolfgang Distler; John F Forbes; Mitch Dowsett; Anthony Howell; Jack Cuzick
Journal:  J Clin Oncol       Date:  2010-06-14       Impact factor: 44.544

Review 10.  The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link.

Authors:  Laura W Bowers; Emily L Rossi; Ciara H O'Flanagan; Linda A deGraffenried; Stephen D Hursting
Journal:  Front Endocrinol (Lausanne)       Date:  2015-05-15       Impact factor: 5.555

View more
  28 in total

Review 1.  The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer.

Authors:  Bruce A Bunnell; Elizabeth C Martin; Margarite D Matossian; Courtney K Brock; Khoa Nguyen; Bridgette Collins-Burow; Matthew E Burow
Journal:  Cancer Metastasis Rev       Date:  2022-08-24       Impact factor: 9.237

Review 2.  Vitamin D deficiency: a potential risk factor for cancer in obesity?

Authors:  Silvia Migliaccio; Andrea Di Nisio; Silvia Magno; Fiammetta Romano; Luigi Barrea; Anna Maria Colao; Giovanna Muscogiuri; Silvia Savastano
Journal:  Int J Obes (Lond)       Date:  2022-01-14       Impact factor: 5.551

Review 3.  Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part I.

Authors:  Mark A Moyad
Journal:  Curr Urol Rep       Date:  2018-10-27       Impact factor: 3.092

4.  Effects of Diet and Exercise-Induced Weight Loss on Biomarkers of Inflammation in Breast Cancer Survivors: A Systematic Review and Meta-analysis.

Authors:  Tyler J Bruinsma; Anne-Marie Dyer; Connie J Rogers; Kathryn H Schmitz; Kathleen M Sturgeon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-03-18       Impact factor: 4.254

5.  Suppression of circulating AP001429.1 long non-coding RNA in obese patients with breast cancer.

Authors:  Hani Choudhry; Mohammed A Hassan; Abdulrahman L Al-Malki; Kaltoom A Al-Sakkaf
Journal:  Oncol Lett       Date:  2021-05-03       Impact factor: 2.967

Review 6.  Signaling Pathways Induced by Leptin during Epithelial⁻Mesenchymal Transition in Breast Cancer.

Authors:  Monserrat Olea-Flores; Juan Carlos Juárez-Cruz; Miguel A Mendoza-Catalán; Teresita Padilla-Benavides; Napoleón Navarro-Tito
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

7.  Double Discourse: Qualitative Perspectives on Breast Screening Participation among Obese Women and Their Health Care Providers.

Authors:  Kate A McBride; Catharine A K Fleming; Emma S George; Genevieve Z Steiner; Freya MacMillan
Journal:  Int J Environ Res Public Health       Date:  2019-02-13       Impact factor: 3.390

Review 8.  Obesity and Energy Balance Considerations in Triple-Negative Breast Cancer.

Authors:  Elizabeth R Berger; Neil M Iyengar
Journal:  Cancer J       Date:  2021 Jan-Feb 01       Impact factor: 3.360

Review 9.  Impact of cholesterol-pathways on breast cancer development, a metabolic landscape.

Authors:  Alina González-Ortiz; Octavio Galindo-Hernández; Gerson N Hernández-Acevedo; Gustavo Hurtado-Ureta; Victor García-González
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

10.  Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer.

Authors:  Bogang Wu; Xiujie Sun; Harshita B Gupta; Bin Yuan; Jingwei Li; Fei Ge; Huai-Chin Chiang; Xiaowen Zhang; Chi Zhang; Deyi Zhang; Jing Yang; Yanfen Hu; Tyler J Curiel; Rong Li
Journal:  Oncoimmunology       Date:  2018-08-23       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.